Related Experiment Videos

Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage

M Amato1, J C Fauchere, U Hermann

  • 1Department of Perinatal Medicine, University Clinic of Obstetrics and Gynecology, Berne, Switzerland.

Neuropediatrics
|August 1, 1988
PubMed

Insights

Preterm infants under 30 weeks gestation with lower fibrinogen and platelet counts face higher risks of peri-intraventricular hemorrhage (PIVH). These hemostatic issues are key factors in PIVH incidence and severity.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Hematology

Background:

  • Peri-intraventricular hemorrhage (PIVH) is a significant complication in preterm infants.
  • Hemostatic abnormalities may contribute to PIVH development and severity.

Purpose of the Study:

  • To investigate the relationship between coagulation status and the incidence/severity of PIVH in preterm infants.
  • To identify specific coagulation parameters associated with PIVH in very preterm neonates.

Main Methods:

  • Prospective study of 54 preterm infants (<35 weeks gestation).
  • Coagulation analyses (fibrinogen, prothrombin time, thrombin time, platelet count) performed.
  • Real-time ultrasound (Echo Scanner) used to document PIVH.
  • Comparison of coagulation values between infants with and without PIVH, and by PIVH grade.

Main Results:

  • 38% of infants developed definite PIVH.
  • Infants <30 weeks gestation with PIVH had significantly lower fibrinogen levels (p<0.03).
  • Lower platelet counts correlated with higher PIVH grades (Grade 3-4 vs. Grade 1-2, p<0.02).

Conclusions:

  • Hemostatic abnormalities, particularly low fibrinogen and platelet counts, are co-factors in neonatal PIVH.
  • These findings are most pronounced in very preterm infants (<30 weeks gestation).
  • Coagulation status is critical in managing and potentially preventing PIVH in high-risk neonates.

Related Concept Videos